US Patent

US8372995 — Crystalline solid forms of tigecycline and methods of preparing same

Formulation · Assigned to Wyeth LLC · Expires 2030-10-08 · 4y remaining

Vulnerability score 53/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects crystalline solid forms of tigecycline, specifically Forms I, II, III, IV, and V, and methods for preparing them.

USPTO Abstract

Crystalline solid forms of tigecycline, Form I, Form II, Form III, Form IV, and Form V, compositions comprising these crystalline solid forms, and processes for preparing these crystalline solid forms are described herein.

Drugs covered by this patent

Patent Metadata

Patent number
US8372995
Jurisdiction
US
Classification
Formulation
Expires
2030-10-08
Drug substance claim
No
Drug product claim
Yes
Assignee
Wyeth LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.